KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) EBT: 2018-2025

Historic EBT for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -$26.9 million.

  • Twist Bioscience's EBT rose 22.65% to -$26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.0 million, marking a year-over-year increase of 63.03%. This contributed to the annual value of -$77.0 million for FY2025, which is 63.03% up from last year.
  • As of Q3 2025, Twist Bioscience's EBT stood at -$26.9 million, which was down 230.61% from $20.6 million recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's EBT registered a high of $20.6 million during Q2 2025, and its lowest value of -$85.4 million during Q2 2024.
  • In the last 3 years, Twist Bioscience's EBT had a median value of -$42.9 million in 2023 and averaged -$40.6 million.
  • Its EBT has fluctuated over the past 5 years, first tumbled by 70.35% in 2021, then skyrocketed by 124.11% in 2025.
  • Twist Bioscience's EBT (Quarterly) stood at -$56.0 million in 2021, then rose by 25.41% to -$41.7 million in 2022, then decreased by 2.73% to -$42.9 million in 2023, then rose by 26.56% to -$31.5 million in 2024, then increased by 22.65% to -$26.9 million in 2025.
  • Its last three reported values are -$26.9 million in Q3 2025, $20.6 million for Q2 2025, and -$39.2 million during Q1 2025.